Vimarsana
Biggest News Aggregation in the World

Page 6 - Marrow Transplant Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marrow Transplant Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marrow Transplant Program Today - Breaking & Trending Today

Phases of Pathophysiology of Chronic GVHD - Vimarsana News

Phases of Pathophysiology of Chronic GVHD

The expert panel explores the immunological aspects of chronic GVHD, highlighting challenges in simultaneous management, addressing fibrosis, and emphasizing the importance of early intervention in evolving transplant care practices.

Acute Versus Chronic Graft-Versus-Host Disease (GVHD) - Vimarsana News

Acute Versus Chronic Graft-Versus-Host Disease (GVHD)

Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz distinguish acute from chronic graft-versus-host disease (GVHD), how such distinction has changed over the last decades, and provide an overview of consensus definitions for disease grading.

A potential cure for thalassemia in the works - Vimarsana News

A potential cure for thalassemia in the works

Hospital’s pioneering gene therapy aims to free patients of blood disease.

NYU Langone Health performs the world's first whole-eye and partial-face transplant for military veteran - Vimarsana News

NYU Langone Health performs the world's first whole-eye and partial-face transplant for military veteran

A surgical team from NYU Langone Health performed the world's first whole-eye and partial-face transplant for a 46-year-old military veteran from Arkansas who survived a work-related high-voltage electrical accident.

A pioneering gene therapy aims to free patients of blood disease. Is a cure at hand? - Vimarsana News

A pioneering gene therapy aims to free patients of blood disease. Is a cure at hand?

After years of blood transfusions, "they think getting cured is totally normal," said Alissa Finlayson.